• 

  Quebec Allows People to Break Federal Laws Around Dementia and Medical Euthanasia
• 

  Alzheimer’s Drugmaker Athira Shells Out $4 Million In DOJ Settlement
• 

  STUDY: Wildfire Smoke Exposure Ups Dementia Risk
• 

  Are Sleep Drugs Safe for People with Dementia?
• 

  U.S. Senate Passes Act Tripling Funding to State and Local Dementia Programs
• 

  Diagnostic Drama: Clinicians Argue Dueling Definitions of Alzheimer’s
• 

  How Bad Is Fraud in Alzheimer’s Research? Q&A With Neurologist-Sleuth Matthew Schrag
• 

  The Brain’s Blood Vessels May Be Driving Cognitive Decline in Women
• 

  Alzheimer’s Treatment Plot Twist: When (Healthy) Amyloid Goes Up, Cognitive Decline Slows Down
• 

  Cassava Drug Simufilam Fails First Phase 3 Trial, Halts Second Phase 3 Trial
• 

  Vaping Linked to Cognitive Impairment in College Students
• 

  Keeping an Eye on Vision Could Help ID Dementia Early—And Help Prevent It
• 

  One Year In, 5 Things We’ve Learned From Patients on Leqembi
• 

  A Round-up of Alzheimer’s Drug Trials News From CTAD 2024
• 

  UK Insurance Didn’t Want to Cover Leqembi. Now, It Says It Won’t Cover Kisunla, Either

Previous91011Next